| Symbol | CERT |
|---|---|
| Name | CERTARA, INC. |
| Sector | TECHNOLOGY |
| Region | North America |
| Industry | Computer Software: Prepackaged Software |
| Address | 100 OVERLOOK CENTER,SUITE 101, PRINCETON, New Jersey, 08540, United States |
| Telephone | +1 609 716-7900 |
| Fax | — |
| — | |
| Website | https://www.certara.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001827090 |
| Description | Certara Inc accelerate medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trial, accelerate regulatory approval and increase patient access to medicines. The group has a business presence in the United States, EMEA and other regions, of which a majority of revenue is derived from the United States. Additional info from NASDAQ: |
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc. - CERT
Read moreCerrado Gold Announces 100% Repurchase of Stream Agreements Over Its Minera Don Nicolas and Lagoa Salgada Projects Held by Sprott
Read moreNew Form 3 - Certara, Inc. <b>Filed:</b> 2026-07-17 <b>AccNo:</b> 0002143915-26-000002 <b>Size:</b> 12 KB
Read moreINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc. - CERT
Read moreCertara to Report Second Quarter 2026 Financial Results on August 4th, 2026
Read moreINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc. - CERT
Read moreCerrado Gold Announces Successful Results of Annual Meeting of Shareholders
Read more